Marcella Petrone - Concepedia

Author

Marcella Petrone

GlaxoSmithKline (Italy)

Also Known As

M Petrone, M. Petrone, MARCELLA PETRONE, Marcella Petrone, Petrone, Marcella

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (Italy)AstraZeneca (United States)AstraZeneca (United Kingdom)AstraZeneca (Sweden)Charité - Universitätsmedizin Berlin

About

Marcella Petrone is an author at GlaxoSmithKline (Italy) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	620
2	Biochemistry	3	3	206
3	Natural Sciences	2	2	88
4	Cell Biology	2	2	60
5	Biomolecular Engineering	1	1	17

Marcella Petrone

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study Phil Ambery, Victoria E R Parker, Michael Stümvoll, The Lancet ObesityMetabolic SyndromeMedicineDiabetesType 2	2018	295
A Comparison Between Different Methods for the Determination of Reduced and Oxidized Glutathione in Mammalian Tissues Maura Floreani, Marcella Petrone, Patrizia Debetto, Free Radical Research Fluorometric AssayGuinea-pig HeartBiochemistryMedicineLipid Peroxidation	1997	118
Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist Victoria E R Parker, Darren Robertson, Tao Wang, The Journal of Clinical Endocrinology & Metabolism	2019	115
Preclinical development of a high affinity α-synuclein antibody, MEDI1341, that can enter the brain, sequester extracellular α-synuclein and attenuate α-synuclein spreading in vivo Darren J. Schofield, Lorraine Irving, Laura Calò, Neurobiology of Disease	2019	110
1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D<sub>3</sub>Receptor Antagonists Fabrizio Micheli, Giorgio Bonanomi, Frank E. Blaney, Journal of Medicinal Chemistry	2007	83
MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study Phil Ambery, Sebastian Klammt, Maximillian G. Posch, British Journal of Clinical Pharmacology	2018	72
Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease Victoria Parker, Thuong Hoang, Heike Schlichthaar, Diabetes Obesity and Metabolism	2022	65
In vitro and in vivo protection against kainate‐induced excitotoxicity by melatonin Pietro Giusti, Davide Franceschini, Marcella Petrone, Journal of Pineal Research	1996	62
Isoindolone derivatives, a new class of 5-HT2C antagonists: Synthesis and biological evaluation Dieter Hamprecht, Fabrizio Micheli, Giovanna Tedesco, Bioorganic & Medicinal Chemistry Letters Medicinal Chemistry5-Ht2c AntagonistsPharmaceutical ScienceDerivative (Chemistry)Biochemistry	2006	52
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase <scp>1 and 2</scp> trials in overweight or obese participants of <scp>A</scp> sian descent with or without type 2 diabetes Michiko Asano, Akiko Sekikawa, Hyosung Kim, Diabetes Obesity and Metabolism	2021	37

Page 1